Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 1028-1035, April 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Laskin, D. L.
Right arrow Articles by Carchman, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laskin, D. L.
Right arrow Articles by Carchman, R. A.

Modulation of Phagocytosis by Tumor Promoters and Epidermal Growth Factor in Normal and Transformed Macrophages1

Debra L. Laskin2, Jeffrey D. Laskin, I. Bernard Weinstein and Richard A. Carchman

Department of Pharmacology, Medical College of Virginia, Richmond, Virginia 23298 [D. L. L., R. A. C.], and Cancer Center/Institute of Cancer Research, Columbia University, College of Physicians and Surgeons, New York, New York 10032 [J. D. L., I. B. W.]

The effects of the potent tumor promoter, 12-O-tetradecanoylphorbol-13-acetate (TPA), on the phagocytosis of opsonized and unopsonized chromated sheep red blood cells (SRBC) by thioglycollate- and divinyl ether maleic anhydride copolymer-recruited mouse peritoneal macrophages, and the transformed macrophage-like cell line, P388D1, were studied. With thioglycollate and divinyl ether maleic anhydride copolymer macrophages, phagocytosis of opsonized SRBC was inhibited 50 to 60% by concentrations of TPA in the range of 17 nM while lower concentrations in the range of 0.017 nM produced a 20 to 30% stimulation of phagocytosis. With the P388D1 cell line, a dose-related stimulation of phagocytosis up to 80% above control was observed with TPA in the range of 0.017 to 17 nM. In all three cell types, phagocytosis of unopsonized SRBC was stimulated by TPA reaching a maximum of 40 to 75% above controls in the range of 17 nM. With a series of macrocyclic diterpenes related to TPA, a correlation was found between their ability to modulate phagocytosis in each of the cell types and their potencies as promoters in mouse skin carcinogenesis. Epidermal growth factor, which shares several effects with TPA, at 0.16 to 16 nM stimulated phagocytosis of unopsonized SRBC by 20 to 60% in all three types of macrophages. On the other hand, with opsonized SRBC, although epidermal growth factor stimulated phagocytosis in P388D1 cells up to 60% above controls at 1.6 nM, it had no effect on thioglycollate or divinyl ether maleic anhydride copolymer macrophages. The responses produced by TPA and epidermal growth factor were due to a direct effect on the macrophages and not to an opsonic effect on the SRBC. These results provide additional evidence that tumor promoters exert highly pleiotropic effects on cell surface and membrane functions.

1 Supported in part by Contract NO-CP-2-3234 of the National Cancer Institute, Department of Health, Education, and Welfare.

2 To whom requests for reprints should be addressed.

Received 8/24/79. Accepted 12/20/79.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.